Dow Up 0.04% Nasdaq Up 0.89%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
5.87 Down 0.01(0.17%) 4:00PM EST
|After Hours : 5.87 Up 0.00 (0.01%) 5:11PM EST
Prev Close:5.88
Open:5.86
Bid:5.85 x 200
Ask:5.98 x 4000
1y Target Est:11.33
Beta:3.84
Next Earnings Date:N/A
Day's Range:5.71 - 5.91
52wk Range:3.11 - 7.82
Volume:2,463,460
Avg Vol (3m):4,587,330
Market Cap:722.98M
P/E (ttm):N/A
EPS (ttm):-0.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXDown 0.17%722.98M
ABTUp 1.16%66.74B
GSKDown 0.28%111.23B
RHHBYUp 0.05%253.79B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.66
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.11
Quarterly EPS Est (Dec-14) :0.23
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-3.77

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback